Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2026-02-20 @ 6:45 PM
Study NCT ID:
NCT01365559
Status:
COMPLETED
Last Update Posted:
2018-03-05
First Post:
2011-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
Sponsor:
Oncotherapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2014-06-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-31
First Submit QC Date:
None
Study First Post Date:
2011-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-01
Last Update Post Date:
2018-03-05
Last Update Post Date Type:
ACTUAL